Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Exemestane
Sponsor: Jules Bordet Institute
Collaborators: Novartis